Pharmaceutical Executive October 17, 2024
Mike Hollan

Slope’s CEO and co-founder discusses technological advances that are solving problems with data collection and sorting from clinical trials.

Clinical trial sites produce massive amounts of data, all of which is important. Thankfully, new technologies are helping pharma companies sort through this data much more efficiently. Rust Felix, CEO and co-founder of Slope, spoke with Pharmaceutical Executive about some of these new technological advances.

Pharmaceutical Executive: How much have Pharma companies struggled with managing data from clinical trials in the past?
Rust Felix: Sponsors have historically grappled with major challenges in managing study data, particularly when it comes to biospecimens. Ensuring sites have the lab kits and supplies they need in order to collect samples from patients is just the first...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Interview / Q&A, Trends
Future Trends for Clinical Trials in 2025 and Beyond
The Future of Clinical Trials: Four Key Trends to Watch in 2025
Small cell lung cancer: Navigating the global clinical trial landscape
Generative AI has ‘potential to revolutionise clinical development’
Treating Covid burnout with ’shrooms

Share This Article